Medford, United States
Morphoceuticals, founded in 2020, is a cutting-edge biotech startup headquartered in the United States. The company's mission, as encapsulated in its slogan "Reprogramming the Software of Life," involves mapping the first druggable bioelectrome.
Specializing in Biotechnology, Health Care, and Life Sciences, Morphoceuticals employs an integrated approach using multi-omics, bioelectric profiling, and AI to revolutionize tissue repair and organ regeneration. By harnessing the body's existing electrical networks, the company aims to offer innovative solutions to some of healthcare's most challenging issues.
The startup recently secured an $8.00M Seed Round investment on 23 January 2023, drawing attention from notable investors such as Juvenescence and Prime Movers Lab. This investment underscores the company's potential for growth and its pioneering position in the bioelectric space. As Morphoceuticals progresses, it offers significant promise for transformation within the biotech industry.
